PERFUSIONSMEDIEN

Patent europeic · EP3099324 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3099324
Numer da la dumonda
EP15742902
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
29-01-2015
Publitgà
07-12-2016
Concedì
01-04-2020
Stritgà
24-08-2023
Motiv
Taxa annuala betg pajada
Classas IPC
C12P 21/02 (2006.01)
C12N 5/02 (2006.01)
Prioritad
US 201461933665 P 30.01.2014
Dumonda PCT
PCT/US2015/013524 29.01.2015
Publicaziun PCT
WO2015/116820 06.08.2015
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 24-08-2023

    Stritgà, taxa betg pajada

    Published in Swissreg on 24.08.2023

  2. 20-06-2020

    Represchentant inscrit

    Representative
    TR-IP Consulting LLC, Route du Coutset 18, 1485 Nuvilly

    Published in Swissreg on 20.06.2020

  3. 01-04-2020

    Concedì

    Published in Swissreg on 01.04.2020

Partidas

Possessur

Coherus BioSciences, Inc.

Coherus Biosciences, Inc.

333 Twin Dolphin Drive Suite 600, Redwood City, CA 94065, US

Represchentant

TR-IP Consulting Sàrl

TR-IP Consulting LLC

Route du Coutset 18, 1485 Nuvilly

En liquidaziun

Inventur

GROVE, James, Russell

Mountain View, CA 94040, US

PUCHACZ, Ela

Pleasanton, CA 94588, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.